Publications

1. Santol J, Kim S, Gregory LA, Baumgartner R, Murtha-Lemekhova A, Birgin E, Gloor S, Braunwarth E, Ammann M, Starlinger J, Pereyra D, Ammon D, Ninkovic M, Kern AE, Rumpf B, Ortmayr G, Herrmann Y, Dong Y, Huber FX, Weninger J, Thiels CA, Warner SG, Smoot RL, Truty MJ, Kendrick ML, Nagorney DM, Cleary SP, Beldi G, Rahbari NN, Hoffmann K, Gilg S, Assinger A, Gruenberger T, Hackl H, Starlinger P. An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure. Ann Surg. 2025 May 1; 281 (5):861-871 Epub 2023 Oct 18
   View PubMed
2. Leiting JL, Alva-Ruiz R, Yonkus JA, Abdelrahman AM, Lynch I, Carlson D, Carr RM, Salomao DR, McWilliams RR, Starlinger PP, Thiels CA, Grotz TE, Warner SG, Cleary SP, Kendrick ML, Smoot RL, Kipp BR, Truty MJ. ASO Visual Abstract: Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer-A Prospective Cohort Study. Ann Surg Oncol. 2025 Apr 10 [Epub ahead of print]
   View PubMed
3. Santol J, Rajcic D, Ortmayr G, Hoebinger C, Baranovskyi TP, Rumpf B, Schuler P, Probst J, Aiad M, Kern AE, Ammann M, Jankoschek AS, Weninger J, Gruenberger T, Starlinger P, Hendrikx T. Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery. JHEP Rep. 2025 Apr; 7 (4):101226 Epub 2024 Oct 04
   View PubMed
4. Zhang C, Lu L, Hanson K, Sultan A, Starlinger P, Smoot R, Kendrick ML, Truty M, Warner SG, Thiels C. Long-Term Reoperation Rates Following Pancreatoduodenectomy for Pancreatic Adenocarcinoma. Am Surg. 2025 Apr; 91 (4):518-527 Epub 2024 Nov 29
   View PubMed
5. Gudmundsdottir H, Graham RP, Greipp PT, Habermann EB, Knudson RA, Brandt CA, Starlinger P, Thiels CA, Warner SG, Smoot RL, Truty MJ, Kendrick ML, Nagorney DM, Cleary SP, Halfdanarson TR. Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors. J Neuroendocrinol. 2025 Apr; 37 (4):e70003 Epub 2025 Feb 13
   View PubMed
6. Leiting JL, Alva-Ruiz R, Yonkus JA, Abdelrahman AM, Lynch IT, Carlson DM, Carr RM, Salomao DR, McWilliams RR, Starlinger PP, Thiels CA, Grotz TE, Warner SG, Cleary SP, Kendrick ML, Smoot RL, Kipp BR, Truty MJ. Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study. Ann Surg Oncol. 2025 Mar 11 [Epub ahead of print]
   View PubMed
7. Ammann M, Gudmundsdottir H, Antwi SKA, Santol J, Podrascanin V, Thiels CA, Warner SG, Truty MJ, Kendrick ML, Smoot RL, Cleary SP, Halfdanarson TR, Nagorney DM, Starlinger PP. Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysis. Eur J Surg Oncol. 2025 Feb 7; 51 (8):109678 Epub 2025 Feb 07
   View PubMed
8. Ammann M, Jonas JP, Pereyra D, Santol J, Hackl H, Kalchbrenner T, Laengle J, Podrascanin V, Lehner F, Viragos-Toth IL, Hulla W, Ruso V, Smoot R, Laengle F, Gruenberger T, Assinger A, Starlinger PP. Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failure. Hepatobiliary Surg Nutr. 2025 Feb 1; 14 (1):49-65 Epub 2025 Jan 17
   View PubMed
9. Ammann M, Adjei Antwi SK, Gudmundsdottir H, Hackl H, Santol J, Guillot BE, Pappalettera G, Thiels CA, Warner SG, Truty MJ, Kendrick ML, Smoot RL, Nagorney DM, Cleary SP, Halfdanarson TR, Starlinger PP. Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasis. Eur J Surg Oncol. 2025 Jan; 51 (1):109464 Epub 2024 Nov 15
   View PubMed
10. Marell P, Kournoutas I, Gile J, Peersen A, Shah P, Babiker H, Kankeu LF, Washburn L, Graham R, Truty M, Starlinger P, Halfdanarson T, Jin Z, Jatoi A, McWilliams R, Borad M, Bekaii-Saab TS, Mahipal A, Ou FS, Tran NH. Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience. Oncologist. 2024 Dec 14 [Epub ahead of print]
    View PubMed
11. Muaddi H, Glasgow A, Abou Chaar MK, Habermann E, Starlinger P, Warner S, Smoot R, Kendrick M, Truty M, Thiels CA. The Influence of Area Deprivation Index on Surgical Outcomes in Pancreas Cancer. J Surg Oncol. 2024 Dec 3 Epub 2024 Dec 03
    View PubMed
12. Pereyra D, Dingfelder J, Riha M, Kacar S, Rauter L, Becker N, Saffarian Zadeh T, Tortopis C, Starlinger P, Ristl R, Silberhumer G, Salat A, Soliman T, Berlakovich G, Gyoeri G. Dual hypothermic oxygenated machine perfusion of the liver reduces post-transplant biliary complications: a retrospective cohort study. Int J Surg. 2024 Dec 1; 110 (12):7909-7918 Epub 2024 Dec 01
    View PubMed
13. Resch U, Hackl H, Pereyra D, Santol J, Brunnthaler L, Probst J, Jankoschek AS, Aiad M, Nolte H, Krueger M, Starlinger P, Assinger A. SILAC-Based Characterization of Plasma-Derived Extracellular Vesicles in Patients Undergoing Partial Hepatectomy. Int J Mol Sci. 2024 Oct 4; 25 (19) Epub 2024 Oct 04
    View PubMed
14. Pereyra D, Mandorfer M, Starlinger P. ASO Author Reflections: Von Willebrand Factor for Assessment of Portal Hypertension and Perioperative Risk in Resectable HCC. Ann Surg Oncol. 2024 Oct; 31 (10):6584-6585 Epub 2024 July 16
    View PubMed
15. Fiorentini G, Bingener J, Hanson KT, Starlinger P, Smoot RL, Warner SG, Truty MJ, Kendrick ML, Thiels CA. Failed recovery after pancreatoduodenectomy: A significant problem even without surgical complications. Surgery. 2024 Oct; 176 (4):992-998 Epub 2024 May 21
    View PubMed
16. Pereyra D, Mandorfer M, Santol J, Gregory L, Koeditz C, Ortmayr G, Schuetz C, Rumpf B, Ammon D, Laengle J, Schwarz C, Jonas JP, Pinter M, Lindenlaub F, Tamandl D, Thiels C, Warner S, Smoot R, Truty M, Kendrick M, Nagorney D, Cleary S, Gruenberger T, Reiberger T, Starlinger P. Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma. Ann Surg Oncol. 2024 Oct; 31 (10):6526-6536 Epub 2024 June 19
    View PubMed
17. Muaddi H, Zironda A, Zhang C, Day C, Starlinger PP, Warner SG, Smoot RL, Kendrick ML, Cleary SP, Truty MJ, Thiels CA. Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. J Surg Oncol. 2024 Sep 5 Epub 2024 Sept 05
    View PubMed
18. Gudmundsdottir H, Fogliati A, Grotz TE, Thiels CA, Warner SG, Smoot RL, Truty MJ, Kendrick ML, Nagorney DM, Halfdanarson TR, Cleary SP, Starlinger P. Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum. Ann Surg Oncol. 2024 Aug; 31 (8):5370-5376 Epub 2024 Apr 30
    View PubMed
19. Ammann M, Gudmundsdottir H, Hackl H, Antwi SKA, Santol J, Habermann EB, Thiels CA, Warner SG, Truty MJ, Kendrick ML, Smoot RL, Nagorney DM, Cleary SP, Halfdanarson TR, Starlinger PP. Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy. Ann Surg Oncol. 2024 Aug; 31 (8):4931-4941 Epub 2024 May 08
    View PubMed
20. O'Donnell CDJ, Naleid N, Siripoon T, Zablonski KG, Storandt MH, Selfridge JE, Hallemeier CL, Conces ML, Jethwa KR, Bajor DL, Thiels CA, Warner SG, Starlinger PP, Atwell TD, Mitchell JL, Mahipal A, Jin Z. Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer. Cancers (Basel). 2024 Jun 29; 16 (13) Epub 2024 June 29
    View PubMed
21. Brunnthaler L, Hammond TG, Pereyra D, Santol J, Probst J, Laferl V, Resch U, Aiad M, Janoschek AS, Gruenberger T, Hackl H, Starlinger P, Assinger A. HMGB1-Mediated Cell Death-A Crucial Element in Post-Hepatectomy Liver Failure. Int J Mol Sci. 2024 Jun 28; 25 (13) Epub 2024 June 28
    View PubMed
22. Zhang C, Zironda A, Vierkant RA, Starlinger P, Warner S, Smoot R, Kendrick M, Cleary S, Truty M, Thiels C. Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy. Ann Surg. 2024 May 1; 279 (5):842-849 Epub 2023 July 27
    View PubMed
23. Ferrari D, Violante T, Novelli M, Starlinger PP, Smoot RL, Reisenauer JS, Larson DW. The death of laparoscopy. Surg Endosc. 2024 May; 38 (5):2677-2688 Epub 2024 Mar 22
    View PubMed
24. Zott T, Pereyra D, Kersten I, Ortner M, Hupper MN, Starlinger P, Berlakovich GA, Silberhumer GR. Characterization of Perioperative Serotonin in Patients Undergoing Orthotopic Liver Transplantation. J Clin Med. 2024 Apr 30; 13 (9)
    View PubMed
25. Breitenecker K, Heiden D, Demmer T, Weber G, Primorac AM, Hedrich V, Ortmayr G, Gruenberger T, Starlinger P, Herndler-Brandstetter D, Barozzi I, Mikulits W. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma. Int J Mol Sci. 2024 Apr 10; 25 (8)
    View PubMed
26. Santol J, Ammann M, Reese T, Kern AE, Laferl V, Oldhafer F, Dong Y, Rumpf B, Vali M, Wiemann B, Ortmayr G, Brunner SE, Probst J, Aiad M, Jankoschek AS, Gramberger M, Tschoegl MM, Salem M, Surci N, Thonhauser R, Mazari V, Hoblaj T, Thalhammer S, Schmelzle M, Oldhafer KJ, Gruenberger T, Starlinger P. Comparison of the LiMAx test vs. the APRI+ALBI score for clinical utility in preoperative risk assessment in patients undergoing liver surgery - A European multicenter study. Eur J Surg Oncol. 2024 Apr; 50 (4):108048 Epub 2024 Feb 21
    View PubMed
27. Fiorentini G, Zironda A, Fogliati A, Warner S, Cleary S, Smoot R, Truty M, Kendrick M, Nagorney D, Thiels C, Starlinger P. The "double-fired" gastro-jejunostomy as a form of improved efficiency during Whipple procedure. HPB (Oxford). 2024 Apr; 26 (4):512-520 Epub 2023 Dec 13
    View PubMed
28. Fogliati A, Zironda A, Fiorentini G, Adjei S, Amro A, Starlinger PP, Grotz TE, Warner SG, Smoot RL, Thiels CA, Kendrick ML, Cleary SP, Truty MJ. Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. Ann Surg Oncol. 2024 Apr; 31 (4):2632-2639 Epub 2024 Feb 06
    View PubMed
29. Watkins R, Gamo A, Choi SH, Kumar M, Buckarma E, McCabe C, Tomlinson J, Pereya D, Lupse B, Geravandi S, Werneburg NW, Wang C, Starlinger P, Zhu S, Li S, Yu S, Surakattula M, Baguley T, Ardestani A, Maedler K, Roland J, Nguyen-Tran V, Joseph S, Petrassi M, Rogers N, Gores G, Chatterjee A, Tremblay M, Shen W, Smoot R. A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis. PNAS Nexus. 2024 Mar; 3 (3):pgae096 Epub 2024 Mar 01
    View PubMed
30. Wei Z, Groeneveld DJ, Adelmeijer J, Poole LG, Cline H, Kern AE, Langer B, Brunnthaler L, Assinger A, Starlinger P, Lisman T, Luyendyk JP. Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy. J Thromb Haemost. 2024 Mar; 22 (3):620-632 Epub 2023 Nov 24
    View PubMed
31. Zironda A, Zhang C, Day C, McWilliams RR, Starlinger P, Warner SG, Smoot RL, Cleary SP, Kendrick ML, Truty MJ, Thiels CA. Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection. HPB (Oxford). 2024 Jan; 26 (1):145-153 Epub 2023 Sept 11
    View PubMed
32. Brunnthaler L, Pereyra D, Brenner M, Santol J, Herrmann L, Schrottmaier WC, Pirabe A, Schmuckenschlager A, Kim S, Kern AE, Huber FX, Michels LE, Brostjan C, Salzmann M, Hohensinner P, Kain R, Gruenberger T, Starlinger P, Assinger A. Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure. Hepatol Commun 2024 Jan 1; 8 (1) Epub 2023 Dec 15
    View PubMed
33. Zhang C, Gudmundsdottir H, Takahashi H, Day C, Glasgow A, Wasif N, Starlinger P, Warner S, Grotz T, Smoot R, Truty M, Cleary S, Kendrick M, Nagorney D, Navin P, Halfdanarson TR, Thiels C. Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection. J Surg Oncol. 2023 Dec; 128 (7):1072-1079 Epub 2023 Aug 02
    View PubMed
34. Chouari T, Merali N, La Costa F, Santol J, Chapman S, Horton A, Aroori S, Connell J, Rockall TA, Mole D, Starlinger P, Welsh F, Rees M, Frampton AE. The Role of the Multiparametric MRI LiverMultiScan(TM) in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis. Cancers (Basel). 2023 Oct 5; 15 (19) Epub 2023 Oct 05
    View PubMed
35. Ammann M, Santol J, Pereyra D, Kalchbrenner T, Wuerger T, Laengle J, Smoot RL, Hulla W, Laengle F, Starlinger P. Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration. Sci Rep. 2023 Sep 25; 13 (1):15980 Epub 2023 Sept 25
    View PubMed
36. Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler CE, Starlinger P, Dasari BVM, Heil J, Sgarbura O, Soreide K, Diaz-Nieto R, Fondevila C, Frampton AE, Geisel D, Henninger B, Hessheimer AJ, Lesurtel M, Mole D, Ollinger R, Olthof P, Reiberger T, Schnitzbauer AA, Schwarz C, Sparrelid E, Stockmann M, Truant S, Aldrighetti L, Braunwarth E, D'Hondt M, DeOliveira ML, Erdmann J, Fuks D, Gruenberger T, Kaczirek K, Malik H, Ofner D, Rahbari NN, Gobel G, Siriwardena AK, Stattner S. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy. Br J Surg. 2023 Sep 6; 110 (10):1331-1347
    View PubMed
37. Gudmundsdottir H, Habermann EB, Vierkant RA, Starlinger P, Thiels CA, Warner SG, Smoot RL, Truty MJ, Kendrick ML, Halfdanarson TR, Nagorney DM, Cleary SP. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients. Ann Surg Oncol. 2023 Aug; 30 (8):4840-4851 Epub 2023 May 19
    View PubMed
38. Vucur M, Ghallab A, Schneider AT, Adili A, Cheng M, Castoldi M, Singer MT, Buttner V, Keysberg LS, Kusgens L, Kohlhepp M, Gorg B, Gallage S, Barragan Avila JE, Unger K, Kordes C, Leblond AL, Albrecht W, Loosen SH, Lohr C, Jordens MS, Babler A, Hayat S, Schumacher D, Koenen MT, Govaere O, Boekschoten MV, Jors S, Villacorta-Martin C, Mazzaferro V, Llovet JM, Weiskirchen R, Kather JN, Starlinger P, Trauner M, Luedde M, Heij LR, Neumann UP, Keitel V, Bode JG, Schneider RK, Tacke F, Levkau B, Lammers T, Fluegen G, Alexandrov T, Collins AL, Nelson G, Oakley F, Mann DA, Roderburg C, Longerich T, Weber A, Villanueva A, Samson AL, Murphy JM, Kramann R, Geisler F, Costa IG, Hengstler JG, Heikenwalder M, Luedde T. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity. 2023 Jul 11; 56 (7):1578-1595.e8 Epub 2023 June 16
    View PubMed
39. Kern AE, Ortmayr G, Assinger A, Starlinger P. The role of microRNAs in the different phases of liver regeneration. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec; 17 (10):959-973 Epub 2023 Oct 24
    View PubMed
40. Gudmundsdottir H, Yonkus JA, Alva-Ruiz R, Kendrick ML, Smoot RL, Warner SG, Starlinger P, Thiels CA, Nagorney DM, Cleary SP, Grotz TE, Truty MJ. Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients. J Am Coll Surg. 2023 Jul 1; 237 (1):49-57 Epub 2023 Apr 07
    View PubMed
41. Fogliati A, Fiorentini G, Alva-Ruiz R, Abdelrahman AM, Zironda A, Lynch IT, Smoot RL, Starlinger PP, Cleary SP, Kendrick ML, Truty MJ. Technical Outcomes of Porto-Mesenteric Venous Reconstruction in Pancreatic Resection Using Autologous Left Renal Vein Graft as Conduit. J Am Coll Surg. 2023 Jul 1; 237 (1):58-67 Epub 2023 June 15
    View PubMed
42. Starlinger P, Brunnthaler L, Watkins R, Pereyra D, Stift J, Finsterbusch M, Santol J, Gruenberger T, Assinger A, Smoot R. Tyrosine phosphorylation of YAP-1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin. J Cell Biochem. 2023 May; 124 (5):687-700 Epub 2023 Mar 22
    View PubMed
43. Starlinger P, Brunnthaler L, McCabe C, Pereyra D, Santol J, Steadman J, Hackl M, Skalicky S, Hackl H, Gronauer R, O'Brien D, Kain R, Hirsova P, Gores GJ, Wang C, Gruenberger T, Smoot RL, Assinger A. Transcriptomic landscapes of effective and failed liver regeneration in humans. JHEP Rep. 2023 Apr; 5 (4):100683 Epub 2023 Feb 02
    View PubMed
44. Santol J, Pereyra D, Haegele S, Ammon D, Ortmayr G, Pirabe A, Jonas JP, Schuster S, Kim S, Nguyen T, Gruenberger T, Assinger A, Starlinger P. The Ratio of Activin A and Follistatin-Like 3 Is Associated With Posthepatectomy Liver Failure and Morbidity in Patients Undergoing Liver Resection. Gastro Hep Adv. 2023; 2 (5):642-651 Epub 2023 Mar 07
    View PubMed
45. Brandel V, Schimek V, Gober S, Hammond T, Brunnthaler L, Schrottmaier WC, Mussbacher M, Sachet M, Liang YY, Reipert S, Ortmayr G, Pereyra D, Santol J, Rainer M, Walterskirchen N, Ramos C, Gerakopoulos V, Rainer C, Spittler A, Weiss T, Kain R, Messner B, Gruenberger T, Assinger A, Oehler R, Starlinger P. Hepatectomy-induced apoptotic extracellular vesicles stimulate neutrophils to secrete regenerative growth factors. J Hepatol. 2022 Dec; 77 (6):1619-1630 Epub 2022 Aug 17
    View PubMed
46. Sparrelid E, Olthof PB, Dasari BVM, Erdmann JI, Santol J, Starlinger P, Gilg S. Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open. 2022 Nov 2; 6 (6)
    View PubMed
47. Alva-Ruiz R, Abdelrahman AM, Starlinger PP, Yonkus JA, Moravec DN, Busch JJ, Fleming CJ, Andrews JC, Mendes BC, Colglazier JJ, Smoot RL, Cleary SP, Nagorney DM, Kendrick ML, Truty MJ. Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer. HPB (Oxford). 2022 Nov; 24 (11):1957-1966 Epub 2022 June 16
    View PubMed
48. Aizpuru M, Starlinger P, Nagorney DM, Smoot RL, Truty MJ, Kendrick ML, Cleary SP. Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesions. HPB (Oxford). 2022 Sep; 24 (9):1416-1424 Epub 2022 Jan 23
    View PubMed
49. De la Cruz Ku G, Aizpuru M, Hackl H, Ubl DS, Habermann EB, Pery R, Driedger M, Assinger A, Nagorney DM, Cleary SP, Smoot RL, Starlinger P. Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality. HPB (Oxford). 2022 Sep; 24 (9):1453-1463 Epub 2022 Feb 26
    View PubMed
50. Watkins RD, Buckarma EH, Tomlinson JL, McCabe CE, Yonkus JA, Werneburg NW, Bayer RL, Starlinger PP, Robertson KD, Wang C, Gores GJ, Smoot RL. SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models. JCI Insight. 2022 Aug 8; 7 (15) Epub 2022 Aug 08
    View PubMed
51. Ortmayr G, Brunnthaler L, Pereyra D, Huber H, Santol J, Rumpf B, Najarnia S, Smoot R, Ammon D, Sorz T, Fritsch F, Schodl M, Voill-Glaninger A, Weitmayr B, Fodinger M, Klimpfinger M, Gruenberger T, Assinger A, Mikulits W, Starlinger P. Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration. Hepatol Commun. 2022 Mar; 6 (3):576-592 Epub 2021 Dec 24
    View PubMed
52. Wagner C, Hois V, Eggeling A, Pusch LM, Pajed L, Starlinger P, Claudel T, Trauner M, Zimmermann R, Taschler U, Lass A. KIAA1363 affects retinyl ester turnover in cultured murine and human hepatic stellate cells. J Lipid Res. 2022 Mar; 63 (3):100173 Epub 2022 Jan 29
    View PubMed
53. Jonas JP, Hackl H, Pereyra D, Santol J, Ortmayr G, Rumpf B, Najarnia S, Schauer D, Brostjan C, Gruenberger T, Starlinger P. Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis. HPB (Oxford). 2022 Jan; 24 (1):116-129 Epub 2021 June 24
    View PubMed
54. Reiterer C, Kabon B, Taschner A, Falkner von Sonnenburg M, Graf A, Adamowitsch N, Starlinger P, Goshin J, Fraunschiel M, Fleischmann E. Perioperative supplemental oxygen and NT-proBNP concentrations after major abdominal surgery - A prospective randomized clinical trial. J Clin Anesth. 2021 Oct; 73:110379 Epub 2021 June 01
    View PubMed
55. Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality. Hepatology. 2021 Sep; 74 (3):1533-1545 Epub 2021 Aug 29
    View PubMed
56. Driedger MR, Yamashita TS, Starlinger P, Mathis KL, Smoot RL, Cleary SP, Nagorney DM. Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysis. HPB (Oxford). 2021 Aug; 23 (8):1277-1284 Epub 2021 Jan 18
    View PubMed
57. Driedger MR, Groeschl R, Yohanathan L, Starlinger P, Grotz TE, Smoot RL, Nagorney DM, Cleary SP, Kendrick ML, Truty MJ. Finding the Balance: General Surgery Resident Versus Fellow Training and Exposure in Hepatobiliary and Pancreatic Surgery. J Surg Educ. 2021 May-Jun; 78 (3):875-884 Epub 2020 Oct 17
    View PubMed
58. Starlinger P, Pereyra D, Hackl H, Ortmayr G, Braunwarth E, Santol J, Najarnia S, Driedger MR, Gregory L, Alva-Ruiz R, Glasgow A, Assinger A, Nagorney DM, Habermann EB, Staetttner S, Cleary SP, Smoot RL, Gruenberger T. Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery. Hepatology. 2021 May; 73 (5):1956-1966 Epub 2021 Mar 16
    View PubMed
59. Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. Int J Mol Sci. 2021 Mar 18; 22 (6)
    View PubMed
60. Starlinger P, Ubl DS, Hackl H, Starlinger J, Nagorney DM, Smoot RL, Habermann EB, Cleary SP. Combined APRI/ALBI score to predict mortality after hepatic resection. BJS Open. 2021 Jan 8; 5 (1)
    View PubMed
61. Stary V, Pandey RV, Strobl J, Kleissl L, Starlinger P, Pereyra D, Weninger W, Fischer GF, Bock C, Farlik M, Stary G. A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses. Sci Immunol. 2020 Oct 16; 5 (52)
    View PubMed
62. Starlinger P, Luyendyk JP, Groeneveld DJ. Hemostasis and Liver Regeneration. Semin Thromb Hemost. 2020 Sep; 46 (6):735-742 Epub 2020 Sept 09
    View PubMed
63. Mussbacher M, Krammer TL, Heber S, Schrottmaier WC, Zeibig S, Holthoff HP, Pereyra D, Starlinger P, Hackl M, Assinger A. Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures. Cells. 2020 Aug 18; 9 (8)
    View PubMed
64. Gyori GP, Pereyra D, Rumpf B, Hackl H, Koditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation. Hepatology. 2020 Aug; 72 (2):584-594 Epub 2020 Apr 23
    View PubMed
65. Reiterer C, Kabon B, von Sonnenburg MF, Starlinger P, Taschner A, Zotti O, Goshin J, Drlicek G, Fleischmann E. The effect of supplemental oxygen on perioperative brain natriuretic peptide concentration in cardiac risk patients - a protocol for a prosprective randomized clinical trial. Trials. 2020 May 12; 21 (1):400
    View PubMed
66. Sladky VC, Knapp K, Soratroi C, Heppke J, Eichin F, Rocamora-Reverte L, Szabo TG, Bongiovanni L, Westendorp B, Moreno E, van Liere EA, Bakker B, Spierings DCJ, Wardenaar R, Pereyra D, Starlinger P, Schultze S, Trauner M, Stojakovic T, Scharnagl H, Fava LL, Foijer F, de Bruin A, Villunger A. E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration. Dev Cell. 2020 Feb 10; 52 (3):335-349.e7 Epub 2020 Jan 23
    View PubMed
67. Braunwarth E, Rumpf B, Primavesi F, Pereyra D, Hochleitner M, Gobel G, Gasteiger S, Gehwolf P, Ofner D, Starlinger P, Stattner S. Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study. PLoS One. 2020; 15 (12):e0243539 Epub 2020 Dec 14
    View PubMed
68. Bruschi FV, Claudel T, Tardelli M, Starlinger P, Marra F, Trauner M. PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells. Hepatol Commun. 2019 Sep; 3 (9):1191-1204 Epub 2019 July 15
    View PubMed
69. Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlbock M, Kampf S, Asenbaum U, Starlinger P, Stremitzer S, Bodingbauer M, Kaczirek K. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Sci Rep. 2019 Jun 10; 9 (1):8421 Epub 2019 June 10
    View PubMed
70. Starlinger P, Hackl H, Pereyra D, Skalicky S, Geiger E, Finsterbusch M, Tamandl D, Brostjan C, Grunberger T, Hackl M, Assinger A. Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures. Hepatology. 2019 Jun; 69 (6):2636-2651 Epub 2019 Apr 10
    View PubMed
71. Gyoeri GP, Pereyra D, Braunwarth E, Ammann M, Jonas P, Offensperger F, Klinglmueller F, Baumgartner R, Holzer S, Gnant M, Laengle F, Staettner S, Gruenberger T, Starlinger P. The 3-60 criteria challenge established predictors of postoperative mortality and enable timely therapeutic intervention after liver resection. Hepatobiliary Surg Nutr. 2019 Apr; 8 (2):111-124
    View PubMed
72. Groeneveld D, Pereyra D, Veldhuis Z, Adelmeijer J, Ottens P, Kopec AK, Starlinger P, Lisman T, Luyendyk JP. Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. Blood. 2019 Mar 14; 133 (11):1245-1256 Epub 2019 Jan 17
    View PubMed
73. Pereyra D, Rumpf B, Ammann M, Perrodin SF, Tamandl D, Haselmann C, Stift J, Brostjan C, Laengle F, Beldi G, Gruenberger T, Starlinger P. The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Mar; 26 (3):791-799 Epub 2019 Jan 07
    View PubMed
74. Seif K, Alidzanovic L, Tischler B, Ibrahim N, Zagrapan B, Rauscher S, Salzmann M, Hell L, Mauracher LM, Budde U, Schmid JA, Jilma B, Pabinger I, Assinger A, Starlinger P, Brostjan C. Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation. Thromb Haemost. 2018 Dec; 118 (12):2074-2085 Epub 2018 Nov 12
    View PubMed
75. Haegele S, Fuxsteiner J, Pereyra D, Koeditz C, Rumpf B, Schuetz C, Schwarz C, Brostjan C, Gruenberger T, Starlinger P. Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection. Sci Rep. 2018 Nov 14; 8 (1):16823
    View PubMed
76. Schweiger T, Liebmann-Reindl S, Glueck O, Starlinger P, Laengle J, Birner P, Klepetko W, Pils D, Streubel B, Hoetzenecker K. Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgery. J Thorac Dis. 2018 Nov; 10 (11):6147-6157
    View PubMed
77. Jakob MO, Schwarz C, Haltmeier T, Zindel J, Pinworasarn T, Candinas D, Starlinger P, Beldi G. Mesh-augmented versus direct abdominal closure in patients undergoing open abdomen treatment. Hernia. 2018 Oct; 22 (5):785-792 Epub 2018 July 19
    View PubMed
78. Starlinger P, Pereyra D, Haegele S, Braeuer P, Oehlberger L, Primavesi F, Kohler A, Offensperger F, Reiberger T, Ferlitsch A, Messner B, Beldi G, Staettner S, Brostjan C, Gruenberger T. Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection. Hepatology. 2018 Apr; 67 (4):1516-1530 Epub 2018 Feb 27
    View PubMed
79. Laengle J, Stift J, Bilecz A, Wolf B, Beer A, Hegedus B, Stremitzer S, Starlinger P, Tamandl D, Pils D, Bergmann M. DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells. Theranostics. 2018; 8 (12):3198-3213 Epub 2018 May 10
    View PubMed
80. Pereyra D, Starlinger P. Shaping the future of liver surgery: Implementation of experimental insights into liver regeneration. Eur Surg. 2018; 50 (3):132-136 Epub 2018 Mar 06
    View PubMed
81. Stift J, Graf A, Schwarz C, Tamandl D, Starlinger P, Herac M, Beer A, Wrba F, Bodingbauer M, Kaczirek K, Stremitzer S. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. Eur J Surg Oncol. 2018 Jan; 44 (1):139-147 Epub 2017 Nov 26
    View PubMed
82. Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, Starlinger P. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. J Hepatol. 2017 Dec; 67 (6):1243-1252 Epub 2017 Aug 24
    View PubMed
83. Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Kloters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. Oncotarget. 2017 Jul 11; 8 (28):46234-46248
    View PubMed
84. Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol. 2017 Apr; 66 (4):724-733 Epub 2016 Dec 18
    View PubMed
85. Mussbacher M, Schrottmaier WC, Salzmann M, Brostjan C, Schmid JA, Starlinger P, Assinger A. Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. PLoS One. 2017; 12 (12):e0188921 Epub 2017 Dec 08
    View PubMed
86. Pereyra D, Offensperger F, Klinglmueller F, Haegele S, Oehlberger L, Gruenberger T, Brostjan C, Starlinger P. Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity. PLoS One. 2017; 12 (4):e0175359 Epub 2017 Apr 13
    View PubMed
87. Alidzanovic L, Starlinger P, Schauer D, Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L, Gruenberger B, Gruenberger T, Brostjan C. The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance. Oncotarget. 2016 Aug 30; 7 (35):57197-57212
    View PubMed
88. Schauer D, Starlinger P, Alidzanovic L, Zajc P, Maier T, Feldman A, Padickakudy R, Buchberger E, Elleder V, Spittler A, Stift J, Pop L, Gruenberger B, Gruenberger T, Brostjan C. Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. Oncoimmunology. 2016 Jun; 5 (6):e1160185 Epub 2016 Mar 22
    View PubMed
89. Kudira R, Malinka T, Kohler A, Dosch M, de Aguero MG, Melin N, Haegele S, Starlinger P, Maharjan N, Saxena S, Keogh A, Stroka D, Candinas D, Beldi G. P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration. Hepatology. 2016 Jun; 63 (6):2004-17 Epub 2016 Mar 17
    View PubMed
90. Starlinger P, Haegele S, Offensperger F, Oehlberger L, Pereyra D, Kral JB, Schrottmaier WC, Badrnya S, Reiberger T, Ferlitsch A, Stift J, Luf F, Brostjan C, Gruenberger T, Assinger A. The profile of platelet alpha-granule released molecules affects postoperative liver regeneration. Hepatology. 2016 May; 63 (5):1675-88 Epub 2015 Dec 28
    View PubMed
91. Haegele S, Reiter S, Wanek D, Offensperger F, Pereyra D, Stremitzer S, Fleischmann E, Brostjan C, Gruenberger T, Starlinger P. Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection. PLoS One. 2016; 11 (11):e0165481 Epub 2016 Nov 03
    View PubMed
92. Reichl P, Fang M, Starlinger P, Staufer K, Nenutil R, Muller P, Greplova K, Valik D, Dooley S, Brostjan C, Gruenberger T, Shen J, Man K, Trauner M, Yu J, Gao CF, Mikulits W. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. Int J Cancer. 2015 Jul 15; 137 (2):385-394 Epub 2015 Jan 13
    View PubMed
93. Stremitzer S, Stift J, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. Eur J Surg Oncol. 2015 Jul; 41 (7):868-74 Epub 2015 Mar 24
    View PubMed
94. Starlinger P, Haegele S, Wanek D, Zikeli S, Schauer D, Alidzanovic L, Fleischmann E, Gruenberger B, Gruenberger T, Brostjan C. Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction. Br J Surg. 2015 Jun; 102 (7):826-36 Epub 2015 Apr 13
    View PubMed
95. Pilat N, Grunberger T, Langle F, Mittlbock M, Perisanidis B, Kappel S, Wolf B, Starlinger P, Kuhrer I, Muhlbacher F, Kandioler D. Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study. Eur J Surg Oncol. 2015 May; 41 (5):683-9 Epub 2015 Feb 25
    View PubMed
96. Stremitzer S, Stift J, Graf A, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases. Ann Surg Oncol. 2015 Apr; 22 (4):1315-23 Epub 2014 Oct 17
    View PubMed
97. Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P. Erratum. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark Med. 2015; 9 (6):617
    View PubMed
98. Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark Med. 2015; 9 (4):327-35
    View PubMed
99. Schweiger T, Nikolowsky C, Starlinger P, Traxler D, Zimmermann M, Birner P, Hegedus B, Dome B, Bergmann M, Mildner M, Klepetko W, Hoetzenecker K, Ankersmit HJ. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases. PLoS One. 2015; 10 (3):e0120724 Epub 2015 Mar 20
    View PubMed
100. Haegele S, Offensperger F, Pereyra D, Lahner E, Assinger A, Fleischmann E, Gruenberger B, Gruenberger T, Brostjan C, Starlinger P. Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction. PLoS One. 2015; 10 (1):e0116985 Epub 2015 Jan 22
     View PubMed
101. Schauer D, Starlinger P, Zajc P, Alidzanovic L, Maier T, Buchberger E, Pop L, Gruenberger B, Gruenberger T, Brostjan C. Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration. BMC Immunol. 2014 Oct 30; 15:50
     View PubMed
102. Starlinger P, Assinger A, Haegele S, Wanek D, Zikeli S, Schauer D, Birner P, Fleischmann E, Gruenberger B, Brostjan C, Gruenberger T. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. Hepatology. 2014 Jul; 60 (1):257-66
     View PubMed
103. Perisanidis C, Mittlbock M, Schoppmann A, Kornek G, Starlinger P, Stift A, Selzer E, Schopper C, Ewers R. Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer. Clin Oral Investig. 2013 Apr; 17 (3):913-9 Epub 2012 May 29
     View PubMed
104. Starlinger P, Alidzanovic L, Schauer D, Maier T, Nemeth C, Perisanidis B, Tamandl D, Gruenberger B, Gruenberger T, Brostjan C. Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation. Br J Cancer. 2012 Sep 4; 107 (6):961-6 Epub 2012 July 31
     View PubMed
105. Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P, Jakab A, Berenyi E, Pavo N, Zimmermann M, Gabriel C, Plass C, Gyongyosi M, Volf I, Ankersmit HJ. Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol. 2012 Sep; 107 (5):292 Epub 2012 Aug 17
     View PubMed
106. Schauer D, Starlinger P, Reiter C, Jahn N, Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A, Gruenberger T, Brostjan C. Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. PLoS One. 2012; 7 (9):e44450 Epub 2012 Sept 04
     View PubMed
107. Starlinger P, Brugger P, Reiter C, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia. 2011 Oct; 13 (10):980-90
     View PubMed
108. Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia. 2011 May; 13 (5):419-27
     View PubMed
109. Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Dis Markers. 2011; 31 (2):55-65
     View PubMed
110. Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost. 2010 Aug; 8 (8):1809-19 Epub 2010 May 12
     View PubMed